392 related articles for article (PubMed ID: 21595033)
21. Urinary Exosomes and Exosomal CCL2 mRNA as Biomarkers of Active Histologic Injury in IgA Nephropathy.
Feng Y; Lv LL; Wu WJ; Li ZL; Chen J; Ni HF; Zhou LT; Tang TT; Wang FM; Wang B; Chen PS; Crowley SD; Liu BC
Am J Pathol; 2018 Nov; 188(11):2542-2552. PubMed ID: 30142333
[TBL] [Abstract][Full Text] [Related]
22. Serum under-galactosylated IgA1 is increased in Japanese patients with IgA nephropathy.
Shimozato S; Hiki Y; Odani H; Takahashi K; Yamamoto K; Sugiyama S
Nephrol Dial Transplant; 2008 Jun; 23(6):1931-9. PubMed ID: 18178603
[TBL] [Abstract][Full Text] [Related]
23. Clinical manifestations of IgA nephropathy combined with thin glomerular basement membrane nephropathy in children.
Ju Hwang Y; Sub Kim D; Woo Ko C; Hyun Cho M; In Park T
Kidney Res Clin Pract; 2013 Sep; 32(3):111-4. PubMed ID: 26877925
[TBL] [Abstract][Full Text] [Related]
24. An increased polymeric IgA level is not a prognostic marker for progressive IgA nephropathy.
van der Boog PJ; van Kooten C; van Seggelen A; Mallat M; Klar-Mohamad N; de Fijter JW; Daha MR
Nephrol Dial Transplant; 2004 Oct; 19(10):2487-93. PubMed ID: 15252166
[TBL] [Abstract][Full Text] [Related]
25. Urinary excretion of low-molecular-weight proteins as prognostic markers in IgA nephropathy.
Peters HP; van den Brand JA; Wetzels JF
Neth J Med; 2009 Feb; 67(2):54-61. PubMed ID: 19299847
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
27. Urine protein profile of IgA nephropathy patients may predict the response to ACE-inhibitor therapy.
Rocchetti MT; Centra M; Papale M; Bortone G; Palermo C; Centonze D; Ranieri E; Di Paolo S; Gesualdo L
Proteomics; 2008 Jan; 8(1):206-16. PubMed ID: 18095357
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
[TBL] [Abstract][Full Text] [Related]
29. Rapidly progressive glomerulonephritis due to anti-glomerular basement membrane disease accompanied by IgA nephropathy: a case report.
Gao B; Li M; Xia W; Wen Y; Qu Z
Clin Nephrol; 2014 Feb; 81(2):138-41. PubMed ID: 23149250
[TBL] [Abstract][Full Text] [Related]
30. Signs and symptoms of thin basement membrane nephropathy: a prospective regional study on primary glomerular disease-The Limburg Renal Registry.
van Paassen P; van Breda Vriesman PJ; van Rie H; Tervaert JW
Kidney Int; 2004 Sep; 66(3):909-13. PubMed ID: 15327380
[TBL] [Abstract][Full Text] [Related]
31. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions.
Jiang L; Zhang JJ; Lv JC; Liu G; Zou WZ; Zhao MH; Zhang H
Nephrol Dial Transplant; 2008 Dec; 23(12):3921-7. PubMed ID: 18603547
[TBL] [Abstract][Full Text] [Related]
32. Pediatric hematuria and thin basement membrane nephropathy: what is it and what does it mean?
Roth KS; Amaker BH; Chan JC
Clin Pediatr (Phila); 2001 Nov; 40(11):607-13. PubMed ID: 11758961
[TBL] [Abstract][Full Text] [Related]
33. [The incidence of renal diseases as diagnosed by biopsy in Hungary].
Sipiczki T; Ondrik Z; Abrahám G; Pokorny G; Túri S; Sonkodi S; Kemény E; Iványi B
Orv Hetil; 2004 Jun; 145(26):1373-9. PubMed ID: 15384747
[TBL] [Abstract][Full Text] [Related]
34. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
[TBL] [Abstract][Full Text] [Related]
35. Urinary platelet factor four (Pf4) levels in mesangial IgA glomerulonephritis and thin basement membrane disease.
Taira K; Hewitson TD; Kincaid-Smith P
Clin Nephrol; 1992 Jan; 37(1):8-13. PubMed ID: 1541068
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the differential urinary protein profile in IgA nephropathy patients of Uygur ethnicity.
Guo Z; Wang Z; Lu C; Yang S; Sun H; Reziw ; Guo Y; Sun W; Yue H
BMC Nephrol; 2018 Dec; 19(1):358. PubMed ID: 30547763
[TBL] [Abstract][Full Text] [Related]
37. Significance of urinary full-length megalin in patients with IgA nephropathy.
Seki T; Asanuma K; Asao R; Nonaka K; Sasaki Y; Oliva Trejo JA; Kurosawa H; Hirayama Y; Horikoshi S; Tomino Y; Saito A
PLoS One; 2014; 9(12):e114400. PubMed ID: 25502002
[TBL] [Abstract][Full Text] [Related]
38. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
39. Clinical course and prognostic factors of clinical early IgA nephropathy.
Shen P; He L; Huang D
Neth J Med; 2008 Jun; 66(6):242-7. PubMed ID: 18689907
[TBL] [Abstract][Full Text] [Related]
40. A candidate gene approach to genetic prognostic factors of IgA nephropathy--a result of Polymorphism REsearch to DIstinguish genetic factors Contributing To progression of IgA Nephropathy (PREDICT-IgAN).
Yamamoto R; Nagasawa Y; Shoji T; Inoue K; Uehata T; Kaneko T; Okada T; Yamauchi A; Tsubakihara Y; Imai E; Isaka Y; Rakugi H
Nephrol Dial Transplant; 2009 Dec; 24(12):3686-94. PubMed ID: 19420105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
